Angiotensin II Activates Nuclear Transcription Factor κB Through AT1and AT2in Vascular Smooth Muscle Cells
- 23 June 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 86 (12) , 1266-1272
Abstract
—Nuclear factor-κB (NF-κB) regulates many genes involved in vascular physiopathology. We have previously observed in vivo NF-κB activation in injured vessels that diminished by angiotensin-converting enzyme inhibition. In the present work, we investigated the effect of angiotensin II (Ang II) on NF-κB activity in rat vascular smooth muscle cells, evaluating the molecular mechanisms and the specific receptor subtype involved. Ang II increased NF-κB DNA binding (5-fold, 10−9mol/L at 1 hour; electrophoretic mobility shift assay), nuclear translocation of p50/p65 subunits, and cytosolic inhibitor κBα (IκBα) degradation. Ang II elicited NF-κB–mediated transcription (transfection of a reporter gene) and expression of NF-κB–related genes (monocyte chemoattractant protein-1 and angiotensinogen). AT1(DUP753) and AT2(PD123319 andCGP42112) receptor antagonists inhibited Ang II–induced NF-κB DNA binding in a dose-dependent manner (≈85% for each one; 10−5mol/L at 1 hour). The AT2agonistp-aminophenylalanine6–Ang II augmented NF-κB binding (4.6-fold, 10−9mol/L at 1 hour), p65 nuclear levels, and transcription of an NF-κB reporter gene. AT1antagonist markedly inhibited NF-κB–mediated transcription and gene expression. Some differences between AT1/AT2intracellular signals were found. Antioxidants and ceramide inhibitors, but not protein kinase C inhibitors, diminished NF-κB activation elicited by both Ang II and the AT2agonist, while tyrosine kinase inhibitors only decreased Ang II–induced NF-κB activity. Our results demonstrate that Ang II activates NF-κB via AT1and AT2, although NF-κB–mediated transcription occurred mainly through AT1. Both receptors share some signaling pathways (oxygen radicals and ceramide); however, tyrosine kinases only participate in AT1/NF-κB responses. These data provide novel insights into Ang II actions, suggesting a potential implication of the AT2in the pathobiology of vascular cells.Keywords
This publication has 22 references indexed in Scilit:
- IκBα Degradation and Nuclear Factor-κB DNA Binding Are Insufficient for Interleukin-1β and Tumor Necrosis Factor-α-induced κB-dependent TranscriptionJournal of Biological Chemistry, 1998
- Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1European Journal of Immunology, 1997
- Life-Death Balance Within the CellScience, 1996
- Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptorNature, 1995
- Collagen Metabolism in Cultured Adult Rat Cardiac Fibroblasts: Response to Angiotensin II and AldosteroneJournal of Molecular and Cellular Cardiology, 1994
- TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdownCell, 1992
- Cardiac Actions of Angiotensin II: Role of an Intracardiac Renin-Angiotensin SystemAnnual Review of Physiology, 1992
- Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition.Hypertension, 1991
- Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathwayBiochemical and Biophysical Research Communications, 1990
- Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin IIBiochemical and Biophysical Research Communications, 1990